Schwab US Dividend Equity ETF ( $SCHD ) has risen by 1.44% in the past week. It has experienced a 5-day net inflow of $764.66 million.
This is due, in part, to market sentiment on some of the ETF’s largest holdings. For example:
- Unitedhealth Group Inc. enters Q2 earnings season with mounting optimism as top analysts at Morgan Stanley and Bernstein SocGen lift or reiterate bullish targets, citing improving Medicare Advantage margins and strong execution at Optum Health. Despite consensus price targets suggesting slight downside, investors are watching for a potential earnings beat, AI-driven cost savings, and a possible upgrade to full‑year guidance.
- Home Depot has quietly outperformed Costco and Target over the past three months, with shares up about 11% even as some analysts turn more cautious. Bernstein’s Zhihan Ma and Wolfe Research now rate the stock a Hold, reflecting concern over valuation after a strong run, though the Street still sees moderate upside with an average target implying around 9% potential gains for investors.
- Merck & Company shares slipped alongside other major drugmakers after news that a U.S. House committee is probing clinical trials in China, raising political and regulatory overhangs for the sector. Even so, Bank of America’s Jason Gerberry reaffirmed a Buy on Merck, highlighting solid fundamentals and setting a $141 price target, with the broader analyst community viewing the stock as a Moderate Buy and forecasting mid‑single‑digit upside from near-record levels.